| Overview |
| bsm-63069r-apc-Cy5.5-100ul |
| phospho-Tau (S202) Monoclonal Antibody, APC-Cy5.5 Conjugated |
| WB |
| Mouse, Rat |
| Human |
| Specifications |
| APC-Cy5.5 |
| Rabbit |
| KLH conjugated Synthesised phosphopeptide derived from human Tau around the phosphorylation site of Ser202 |
| S202 |
| Monoclonal |
| IgG |
| Lot Dependent |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 4137 |
| P10636 |
| Cytoplasm, Cell membrane |
| Tau(Phospho-Ser202); MAPT(phospho 202); phospho-MAPT Tau（pSer202? p-Tau(Ser202); MAPT; Microtuble-associted protein Tau; AI413597; AW045860; DDPAC; Disinhibition dementia parkinsonism amyotrophy complex; FLJ31424; FTDP 17; FTDP17; G Protein beta 1 gamma 2 subunit interacting factor 1; G protein beta1/gamma2 subunit interacting factor 1; MAPTL; MGC134287; MGC138549; MGC156663; Microtubule associated protein tau isoform 4; MSTD; Mtapt; MTBT1; MTBT2; Neurofibrillary tangle protein; Paired helical filament tau; PHF tau; PHF-tau; PPND; pTau; RNPTAU; Tauopathy and respiratory failure, included; TAU_HUMAN. |
| Application Dilution |
| WB |
1:300-5000 |
Powered by Bioz